跳至主要内容
临床试验/IRCT20151028024760N5
IRCT20151028024760N5尚未招募2 期

Evaluation of the effects of supplementation extract prepared from Capparis spinosa on clinical manifestations, para-clinical and immunological factors in patients with refractory rheumatoid arthritis.

Mashhad University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 60 years(—)
性别
All

入选标准

  • Resistant rheumatoid arthritis (RA) patients to non-biological disease-modifying anti-rheumatic drugs (DMARDs) Treated RA patients by non-biological drugs Treated RA patients by Prednisolone, Hydroxychloroquine, Sulfasalazine and Methotrexate Refractory RA patients with no other Rheumatic disorders and inflammatory diseases

排除标准

  • Non-resistant RA patients to non-biological disease-modifying anti-rheumatic drugs (DMARDs)

研究者

相似试验